Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_1
4
100%

Phase Distribution

4

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Other(3)

Detailed Status

unknown2
Suspended1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 14 (100.0%)

Trials by Status

unknown250%
suspended125%
not_yet_recruiting125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingphase_1

CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

NCT06641453
unknownphase_1

Novel GPC3 CAR-T Cell Therapy for Hepatocellular Carcinoma

NCT05344664
suspendedphase_1

GPC3-CAR-T Cells for the Hepatocellular Carcinoma

NCT04506983
unknownphase_1

A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART)

NCT03130712

Clinical Trials (4)

Showing 4 of 4 trials
NCT06641453Phase 1

CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

Not Yet Recruiting
NCT05344664Phase 1

Novel GPC3 CAR-T Cell Therapy for Hepatocellular Carcinoma

Unknown
NCT04506983Phase 1

GPC3-CAR-T Cells for the Hepatocellular Carcinoma

Suspended
NCT03130712Phase 1

A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART)

Unknown

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4